- Report
- March 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- February 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- February 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- June 2025
- 190 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- January 2025
- 180 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- January 2025
- 180 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- March 2025
- 185 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- March 2025
- 182 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- February 2025
- 180 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- February 2025
- 180 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1431EUR$1,600USD£1,258GBP
€1789EUR$2,000USD£1,573GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1074EUR$1,200USD£944GBP
€1342EUR$1,500USD£1,180GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1431EUR$1,600USD£1,258GBP
€1789EUR$2,000USD£1,573GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1431EUR$1,600USD£1,258GBP
€1789EUR$2,000USD£1,573GBP
- Report
- August 2025
- 180 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- December 2024
- 200 Pages
Global
From €3355EUR$3,750USD£2,950GBP
- Report
- February 2025
- 233 Pages
Global
From €2237EUR$2,500USD£1,966GBP
- Report
- January 2025
- 199 Pages
Global
From €2237EUR$2,500USD£1,966GBP
- Report
- May 2025
- 114 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- September 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,028GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more